ACORAI
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to improve outcomes in HF patients. The device has been clinically validated, designated FDA Breakthrough Device and will be entering the market in 2025. Acorai is a MedTech company with HQ in Sweden. The company has 20 FTE across 12 countries, with offices in Sweden and the UK.
ACORAI
Industry:
Health Care Medical Device Pharmaceutical
Founded:
2019-08-20
Address:
Helsingborg, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.acorai.com
Total Employee:
11+
Status:
Active
Contact:
+46708756781
Total Funding:
11.43 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta LetsEncrypt SSL By Default Mobile Non Scaleable Content HSTS Apple Mobile Web App Capable Google Code Prettify October CMS CityNet
Similar Organizations
ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
ARTIDIS
ARTIDIS is committed to innovation and excellence in order to bring the future of health care to people.
flipMD
Connecting physicians to side gigs. Built by physicians for physicians.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
CardioSignal
Cardiac monitoring via smartphone
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Synapse Medicine
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Terns Pharmaceuticals
Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.
Vasowatch
Deploying decision support technology to improve maternal outcomes and health equity.
Current Advisors List
Board_member
2022-04-01
Current Employees Featured
Filip Peters CEO & Co-founder @ Acorai
CEO & Co-founder
2019-08-20
Jakob Gelberg CTO & Co-founder @ Acorai
CTO & Co-founder
2020-10-01
Kasper Bourdette COO & Co-founder @ Acorai
COO & Co-founder
2020-10-01
Matthew Mace CSO & Director of Sales @ Acorai
CSO & Director of Sales
2022-01-12
Cathy Morin Head of Quality & Regulatory @ Acorai
Head of Quality & Regulatory
2023-08-07
Helmine Verhoeven Head of Clinical @ Acorai
Head of Clinical
2022-11-23
Dan Vikström HR Manager @ Acorai
HR Manager
2022-01-17
Rita Peixoto Clinical Affairs Manager @ Acorai
Clinical Affairs Manager
2022-10-01
Armand Meynadier Hardware Product Development Manager @ Acorai
Hardware Product Development Manager
2023-01-09
Johannes Gladisch R&D Project Manager @ Acorai
R&D Project Manager
2023-05-01
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Acorai
Solardis Health Ventures
Solardis Health Ventures investment in Seed Round - Acorai
CerraCap Ventures
CerraCap Ventures investment in Seed Round - Acorai
Chris Gasteratos
Chris Gasteratos investment in Seed Round - Acorai
KHP Ventures
KHP Ventures investment in Seed Round - Acorai
Carma Fund
Carma Fund investment in Seed Round - Acorai
European Innovation Council
European Innovation Council investment in Grant - Acorai
Springboard Health Angels
Springboard Health Angels investment in Seed Round - Acorai
Golden Angels Investors
Golden Angels Investors investment in Seed Round - Acorai
Capital Q® Ventures Inc.
Capital Q® Ventures Inc. investment in Seed Round - Acorai
Official Site Inspections
http://www.acorai.com Semrush global rank: 2.19 M Semrush visits lastest month: 9.13 K
- Host name: frault1.hostarmada.net
- IP address: 172.105.80.154
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
Acorai.com lookup results from whois.registrar.amazon.com server:
- Domain created: 15th-May-2020
- Domain updated: 10th-Apr-2025
- Domain expires: 15th-May-2026 1 Year, 31 Days left
- Website age: 4 Years, 333 Days
- Registrar Domain ID: 2526379408_DOMAIN_COM-VRSN
- Registrar Url: http://registrar.amazon.com
- Registrar WHOIS Server: whois.registrar.amazon.com
- Registrar Abuse Contact Email: trustandsafety@support.aws.com
- Registrar Abuse Contact Phone: +1.2024422253
- Name server:
- NS-1266.AWSDNS-30.ORG
- NS-15.AWSDNS-01.COM
- NS-1952.AWSDNS-52.CO.UK
- NS-716.AWSDNS-25.NET
More informations about "Acorai"
Acorai - Crunchbase Company Profile & Funding
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a …See details»
Acorai – non-invasive and scalable intracardiac pressure monitoring
The Acorai Heart Monitor has been designed to offer accurate, personalized, and efficient care for heart failure patients. Absolute The Save Sensor System: First-of-its-kind hardware …See details»
Acorai Company Profile 2025: Valuation, Funding & Investors
Acorai General Information Description. Developer of a scalable medical device designed for non-invasive intracardiac pressure monitoring to improve heart failure management. The company …See details»
Our Team – Acorai
Acorai has built a global advisory board of medical device executives, world-leading expert physicians, and thought leaders across healthcare with deep understanding of heart failure …See details»
Our Team - Acorai
Meet The Team Accorai has built a multi-disciplinary team with demonstrated experience across medical devices, with experience from large device manufacturers and startups. Meet Advisory Board Acorai has built a global …See details»
Acorai - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Acorai - NAVA
Location Helsingborg, Sweden Revenue size 0 (Pre-revenue) Year founded 2019 Funding raised EUR 1.6 million Founders Filip Peters, Jakob Gelberg, Kasper Bourdette Most relevant investors Bayer Team size 10-19 Website …See details»
Acorai - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Acorai . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Acorai has 2 board members and advisors, …See details»
Acorai - NOME
Acorai Acorai is developing a medical device for non-invasive monitoring of intracardiac pressure to help reduce re-hospitalizations due to heart failure and can lower mortality rates. Through a unique combination of visual, seismic, …See details»
Product - Acorai
Product Acorai generates data to aid in heart failure management. Our mission is to empower healthcare professionals with the tools they need to deliver the highest quality care to their patients. Contact Acorai Product Acorai generates …See details»
Acorai - EU-Startups
Acorai was founded in 2019 and is headquartered in Skane, Sweden. Acorai is developing the next heart failure vital sign tool to improve standard of care for heart failure patients. Acorai is …See details»
MedTech Strategist - Acorai Serves Up Long-Desired Noninvasive ...
Oct 23, 2024 A companion article to "Devices for Many-Faceted Heart Failure." Acorai has developed a new sensor called SAVE for noninvasively measuring cardiac and pulmonary …See details»
Acorai - Products, Competitors, Financials, Employees, …
Acorai. 's Products & Differentiators. Acorai Device. The Acorai device is a non-invasive, multi-sensor platform designed to monitor cardiac and pulmonary pressures accurately. It integrates …See details»
Acorai news - Acorai closes $4.5M investment from the EIC Fund
Nov 27, 2024 Acorai, a Swedish developer and manufacturer of innovative devices for heart failure management, announced the closing of a $4.5M investment from the EIC Fund, Taiwan …See details»
Acorai - TechCrunch
Acorai. The new standard in heart failure management. Non-invasive and scalable solution to support healthcare professionals with managing intracardiac pressures. Europe, ...See details»
Partnerships and Progress: Acorai’s Journey to Better Heart Health
Aug 23, 2024 Matthew Mace, Acorai’s Chief Science Officer, explains the uniqueness of their approach: "We have integrated various sensor technologies to develop a robust and non …See details»
Acorai receives Breakthrough Device Designation for their non …
HELSINGBORG, Sweden, Aug. 10, 2023 /PRNewswire/ — Acorai, a start-up medical device manufacturer from Sweden, today announces that the U.S. Food and Drug Administration …See details»
Heart Failure start-up, Acorai, embarks on the next vital stage …
HELSINGBORG, Sweden, Aug. 16, 2023 /PRNewswire/ – Today, Acorai, a start-up medical device manufacturer from Sweden, has announced the initiation of a global clinical trial with …See details»
Partner Mona Dajani Reappointed to the ACORE Board of Directors
2 days ago HOUSTON, TX, January 8, 2025 – Baker Botts L.L.P., a leading international energy, technology, and life sciences law firm, is proud to announce that partner Mona Dajani …See details»
News & Blog - Acorai
Nov 27, 2024 The Acorai device has not been evaluated by the FDA for safety or effectiveness and is not cleared by the FDA for clinical use. Granting a Breakthrough Device Designation …See details»